3.0
19 Aug 2013
Current employee, more than 5 years
San Francisco, CA
Recommend
CEO approval
Business outlook
Pros
Work with smart, dedicated people Products created are for the betterment of people
Cons
Reorg within the Life Sciences (LST) has killed confidence and enthusiasm All company assets have moved to Boston area, limiting options for advancement With all the restructuring, R&D progress is stalled and excitement of product creation no longer there